BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 12, 2007
View Archived Issues
Recent patents disclose novel analgesic agents
Read More
New treatment strategy for microbial infections claimed in recent Novozymes patent
Read More
Recent Asahi Kasei patent reports novel agents for treating glaucoma
Read More
MediGene and JDRF collaborate on mTCR therapeutics for type 1 diabetes
Read More
Novel glucocorticoid receptor agonist shows in vivo efficacy and improved safety profile
Read More
DELTA MI trial shows beneficial effects of KAI-9803 in myocardial infarction
Read More
Synergy seen with verotoxin-1 and monophosphoryl lipid A in mouse fibrosarcoma
Read More
Garenoxacin effective for Streptococcus pneumoniae respiratory tract infections
Read More
New data on hepatitis C treatments including pegylated interferon reported
Read More
Viral kinetics, mechanism of action of DEBIO-025 explored
Read More
[N-MeIle4]-cyclosporin and NM-107 exert synergistic anti-HCV activity in vitro
Read More
Pilot bioavailability study for immediate release CDT-fenofibrate tablets
Read More
FDA extends review period for Torisel NDA
Read More
Inhibitex to acquire FermaVir
Read More
MAESTRO-01 trial of MBP-8298 cleared to continue
Read More
ACR-16 studied in new phase Ib trial for schizophrenia
Read More
Enrollment completed in phase III trials of PF-3512676 for NSCLC
Read More
Renovis and Pfizer extend VR1 research collaboration
Read More
Dosing begins in phase I study of AC-220 for AML
Read More
Roche and Transgene establish HPV collaboration
Read More
Reolysin studied in phase II trial for metastatic sarcomas
Read More
Pancreatic cancer study of Erbitux plus gemcitabine misses endpoint
Read More
Swiss approval for phase III trial of CUV-1647 for erythropoietic protoporphyria
Read More
ARRY-797 to be studied in cancer patients
Read More
Protemix raises funds to advance pipeline
Read More
Imbalance in cardiovascular and neoplasm SAEs in alvimopan trial
Read More
PS-433540 well tolerated and potentially suited for once-daily administration
Read More
Follistim introduced in Japan for induction of ovulation in infertile women
Read More
Brovana available in U.S.
Read More